Skip to main content
. 2023 Apr 12;25(8):1455–1464. doi: 10.1093/ntr/ntad058

Table 2.

Estimated Hazard Function* (95% Confidence Interval) of the Onset of Mental Health Symptoms Stratified by Use Status and Cohort in Youth/Emerging Adults, W9–W14, TATAMS

Ever cigarette use Ever e-cigarette use Ever cannabis use
No Yes No Yes No Yes
Age (years) Depressive symptoms
Cohort 1
15 0.0 0.0 0.0 0.0 0.0 0.0
16 0.2 (0.1–0.5) 1.3 (0.5–3.5) 0.4 (0.2–1.0) 1.7 (1.0–2.9) 0.2 (0.1–0.7) 0.5 (0.2–1.4)
17 8.1 (7.2–9.2) 11.4 (8.6–15.1) 7.5 (6.5–8.7) 10.8 (9.0–13.1) 7.8 (6.7–9.1) 9.7 (8.0–11.6)
18 23.4 (19.5–22.6) 23.9 (19.3–28.7) 14.4 (12.9–16.0) 23.8 (21.1–26.8) 16.2 (14.5–18.1) 23.8 (21.2–26.6)
19* 45.7 (42.3–45.9) 74.1 (68.8–79.1) 35.6 (33.4–37.9) 53.1 (49.4–56.9) 41.2 (38.1–44.6) 63.7 (60.0–67.3)
Cohort 2
17 0.0 0.0 0.0 0.0 0.0 0.0
18 0.2 (0.1–0.6) 0.3 (0.1–0.9) 0.2 (0.1–0.7) 0.3 (0.2–0.8) 0.2 (0.1–0.7) 0.2 (0.1–0.7)
19 6.3 (5.4–7.3) 5.4 (4.2–6.9) 6.6 (5.5–7.8) 5.4 (4.4–6.6) 6.5 (5.4–7.8) 6.0 (4.9–7.2)
20 16.2 (14.8–17.8) 19.5 (17.3–33.0) 17.0 (15.2–18.8) 20.4 (15.7–22.4) 12.5 (11.0–14.2) 20.7 (18.9–22.6)
21.5 46.3 (43.7–49.1) 57.7 (54.5–60.9) 43.2 (41.9–45.8) 53.5 (50.9–56.2) 37.0 (33.4–40.8) 55.2 (52.8–57.7)
22 N/A 66.2 N/A 62.8 N/A 61.6 (57.7–65.50)
Cohort 3
18 0.0 0.0 0.0 0.0 0.0 0.0
19 0.2 (0.1–0.6) 0.5 (0.3–1.1) 0.3 (0.1–1.0) 0.3 (0.1–0.6) 0.4 (0.1–1.1) 0.8 (0.5–1.2)
20 3.7 (3.0–4.6) 2.9 (2.1 –3.1) 3.3 (2.5–4.4) 3.5 (3.2–5.1) 3.0 (2.2–4.1) 3.5 (2.9–4.3)
21 11.6 (10.4–13.1) 10.3 (9.0 –11.8) 12.1 (10.6–13.9) 10.9 (9.7–12.1) 11.4 (9.8–13.2) 11.2 (10.0–12.4)
22 23.7 (22.0–25.6) 27.9 (25.8–30.2) 25.4 (23.2–27.7) 29.7 (27.8–31.6) 17.5 (15.6–19.7) 29.8 (28.0–31.6)
23 46.5 (43.9–49.0) 48.5 (46.0–51.0) 42.8 (39.6–46.1) 49.8 (47.7–51.9) 39.7 (37.0–42.6) 51.3 (49.3–53.4)
24 64.5 (60.2–68.9) 66.2 (60.3–72) 56.5 (51.7–61.5) 65.8 (59.7–71.9) 52.0 (49.1–55.1) 65.7 (59.8–71.5)
Anxiety symptoms
Cohort 1
15 0.0 0.0 0.0 0.0 0.0 0.0
16 0.3 (0.2–0.7) 0.6 (0.1–2.6) 0.2 (0.1–0.6) 0.6 (0.3–1.6) 0.3 (0.1–0.2) 0.5 (0.2–1.4)
17 7.4 (6.1–9.5) 8.6 (6.2–11.9) 8.3 (7.2–9.6) 8.4 (6.8–10.3) 8.1 (6.9–9.4) 6.2 (4.8–7.9)
18 21.7 (20.1–23.3) 27.0 (22.8–31.9) 21.8 (20.1–23.7) 22.5 (19.8–25.5) 22.0 (20.1–23.9) 22.3 (19.9–25.0)
19* 51.8 (49.5–54.2) 68.9 (64.1–73.5) 53.3 (50.2–56.6) 57.4 (54.0–60.8) 47.0 (42.6–51.7) 63.3 (59.8–66.8)
Cohort 2
17 0.0 0.0 0.0 0.0 0.0 0.0
18 0.2 (0.1–0.6) 0.3 (0.1–0.8) 0.3 (0.1–0.9) 0.2 (0.1–0.6) 0.4 (0.2–1.0) 0.1 (0.0–0.5)
19 5.5 (4.7–6.4) 4.9 (3.8–6.4) 5.9 (4.9–7.0) 4.6 (3.7–5.8) 6.7 (5.6–8.0) 4.5 (3.7–5.6)
20 16.9 (15.5–18.5) 18.8 (16.6–21.2) 17.1 (15.4–19.0) 17.8 (16.1–19.7) 13.8 (12.3–15) 19.1 (17.4–21.0)
21 37.6 (35.6–40.7) 51.8 (48.6–55.2) 38.1 (35.7–40.5) 46.6 (43.9–49.3) 32.9 (30.5–35.4) 48.1 (45.5–50.8)
22 53.2 (49.9–56.5) 60.3 (57.1–63.6) 52.5 (48.8–56.3) 57.7 (54.9–60.4) 53.7 (49.9–57.6) 58.3 (61.1–73.7)
Cohort 3
18 0.0 0.0 0.0 0.0 0.0 0.0
19 0.3 (0.1–0.6) 0.4 (0.2–1.0) 0.5 (0.2–1.2) 0.5 (0.3–1.1) 0.7 (0.3–1.4) 0.8 (0.5–1.2)
20 3.6 (2.9–4.5) 2.5 (1.9–3.4) 4.4 (3.5–5.6) 2.1 (1.7–2.8) 3.6 (3.0–4.8) 2.7 (2.1–3.4)
21 11.2 (10.0–12.6) 11.6 (10.1–13.2) 11.4 (9.9–13.2) 11.1 (9.9–12.4) 10.8 (9.2–12.6) 12.5 (11.3–13.8)
22 26.8 (25.0–28.8) 30.6 (28.5–32.7) 25.3 (23.1–27.6) 30 (28.3–31.8) 30.0 (21.6–26.5) 30.1 (28.5–31.9)
23 42.5 (40.5–44.6) 53.0 (50.7–55.3) 43.6 (41–46.3) 50.7 (48.7–52.7) 39.1 (36.5–41.8) 51.3 (49.3–53.3)
24 57.7 (55.7–59.7) 63.8 (60.0–67.6) N/A 71.9 (67.8–75.9) 44.6 (41.7–51.1) 70.0 (65.9–73.9)

Bold indicates statistical significance, p < .05.

Hazards are reported as cumulative percentages (ie, cumulative incidence).

N/A: there was not enough sample size to estimate a stable initiation at this age.

*This age represents 19 years old and 4 months.